| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.09B | -8.8% |
| Cost of Revenue | $12.39B | -7.2% |
| R&D Expense | $1.02B | +10.9% |
| SG&A Expense | $1.88B | +9.6% |
| Pre-tax Income | $620.0M | -57.4% |
| Income Tax | $184.0M | -45.2% |
| Net Income | $510.0M | -59.1% |
| EPS (Basic) | $0.41 | -58.6% |
| EPS (Diluted) | $0.41 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.58B | -19.2% |
| Inventory | $4.65B | -2.6% |
| Total Assets | $42.75B | -0.4% |
| Total Liabilities | $34.92B | -0.7% |
| Stockholders' Equity | $7.77B | +0.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.54B | +29.0% |
| Investing Cash Flow | -$1.38B | +50.2% |
| Financing Cash Flow | -$2.02B | -2914.9% |
| -58.6% |